Skip to content

TARGET XL M0036102250Recalls & reported problems

Stryker Corporation · 360 Standard Detachable Coil · Class 2 · Implant

All models of TARGET XL (34)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613327004748), received between Nov 23, 2019 and Nov 23, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Separation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Premature Separation1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 23, 2019Premature Separation; Premature Separation

    IT WAS REPORTED THAT DURING PROCEDURE, WHILE DEPLOYING A SECOND STENT (SUBJECT DEVICE), THE COIL PREMATURELY DETACHED WITHIN THE MICROCATHETER (NON-STRYKER DEVICE). THE MAIN COIL WAS OUTSIDE THE CATHETER AND THE REMAINING PART WAS ENTIRELY INSIDE THE MICROCATHETER. THE DETACHED COIL WAS COMPLETELY REMOVED FROM THE PATIENT¿S BODY BY WITHDRAWAL OF CATHETER WITH THE COIL INSIDE THE MICROCATHETER. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9367077 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page